Page last updated: 2024-11-06

thyroxine and Fatigue Syndrome, Chronic

thyroxine has been researched along with Fatigue Syndrome, Chronic in 3 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Sun, Q1
Oltra, E1
Dijck-Brouwer, DAJ1
Chillon, TS1
Seemann, P1
Asaad, S1
Demircan, K1
Espejo-Oltra, JA1
Sánchez-Fito, T1
Martín-Martínez, E1
Minich, WB1
Muskiet, FAJ1
Schomburg, L1
Shepherd, C1
Weetman, AP1

Reviews

1 review available for thyroxine and Fatigue Syndrome, Chronic

ArticleYear
Thyroxine treatment in biochemically euthyroid but clinically hypothyroid individuals.
    Clinical endocrinology, 2002, Volume: 57, Issue:1

    Topics: Depressive Disorder; Diagnosis, Differential; Fatigue Syndrome, Chronic; Humans; Hypothyroidism; Mid

2002

Other Studies

2 other studies available for thyroxine and Fatigue Syndrome, Chronic

ArticleYear
Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone.
    Redox biology, 2023, Volume: 65

    Topics: Autoantibodies; Fatigue Syndrome, Chronic; Humans; Selenium; Selenoprotein P; Selenoproteins; Thyrot

2023
Giving thyroid hormones to clinically hypothyroid but biochemically euthyroid patients. Long-term treatment is being used.
    BMJ (Clinical research ed.), 1997, Sep-27, Volume: 315, Issue:7111

    Topics: Fatigue Syndrome, Chronic; Humans; Hypothyroidism; Long-Term Care; Reference Values; Thyroxine

1997